About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

By: via Business Wire

Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will be featured in several presentations and a live case transmission featuring the nsPFA 360° catheter mapped with the CARTO™ 3 Mapping System from Johnson & Johnson MedTech at the Heart Rhythm Society (HRS) 2025 Annual Meeting, being held April 24-27 in San Diego, California.

“We are gaining significant momentum generating clinical and preclinical evidence in support of our nanosecond PFA technology and are thankful for the clinicians who will be sharing the positive results they are achieving clinically with our 360° catheter for the treatment of AF and preclinically with our focal catheter,” said Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences. “2025 is shaping up to be a milestone year for Pulse Biosciences. Our early clinical work has positioned us to initiate our IDE pivotal trial to support FDA approval of the Nanosecond PFA 360° Cardiac Catheter System in the middle of the year where we will further leverage the support of the KOLs in attendance at this year’s HRS meeting.”

In addition to its booth and technology suite, Nanosecond PFA Technology will be featured at several events at the HRS 2025 Annual Meeting including:

Thursday, April 24, 2025

PFA Live Case Summit

Time:

8:00 am to 9:30am PT

Location:

San Diego Convention Center – Room 20A

 

Session I – Live PFA Cases

 

Live Case: PVI+PWA Using Nanosecond PFA

 

Live Case Site: Na Homolce Hospital, Prague, CZ.

 

Live Case Operations: Jan Petru, MD, and Moritoshi Funasako, MD, PhD

Presentation | Dose-based Lesion Titration using Focal Nanosecond Pulsed Electric Field Ablation: A Preclinical Assessment

Time:

5:00pm to 6:30 pm PT

Location:

Sails Pavilion - Poster Area

 

Masaya Shinohara, Keita Watanabe, Fengyuan Yu, Abhishek Maan, William Whang, Srinivas R. Dukkipati, Vivek Y. Reddy, Jacob S. Koruth

 

Icahn School of Medicine at Mount Sinai, New York, NY

 

Saturday, April 26th

Presentation | Feasibility and Durability of Pulmonary Vein Isolation and Posterior Left Atrial Wall Ablation Using Nanosecond Pulse Field Ablation: A First-in-Human Clinical Experience

Time:

8:00am to 8:10am PT

Location:

Oral Abstracts Hub 1 - Sails Pavillion

 

Petr Neuzil MD PhD, Jan Petru MD, Moritoshi Funasako, MD, Jacob S. Koruth MD Pavel Hala, MD, Jan Skoda, MD, PhD, Vivek Y. Reddy, MD

 

Homolka Hospital, Prague, Czech Republic; Mount Sinai Fuster Heart Hospital, New York, NY

Presentation | Poster Session IV

Time:

9:30 am to 11:30am PT

Location:

Exhibit Hall

 

Nanosecond PFA Utilizing A Novel Focal Catheter with a Novel Mapping System: Initial Lab Experience

 

Aqeel Khanani MD, Usman Siddiqui MD, Lakeland Regional Health in Lakeland, Florida

About Pulse Biosciences®

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation.

Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA, nanosecond PFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the effectiveness of the Company’s CellFX nsPFA technology, statements concerning the Company’s expected product development efforts, such as advancement of its nsPFA 360° Cardiac Catheter to treat atrial fibrillation, statements concerning early clinical and pre-clinical successes and whether they are predictive of the safety and efficacy of any medical device such as the nsPFA 360° Cardiac Catheter, Pulse Biosciences’ expectations, whether stated or implied, regarding its future clinical studies and regulatory submissions, and other future events. These statements are not historical facts but rather are based on Pulse Biosciences’ current expectations, estimates, and projections regarding Pulse Biosciences’ business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences’ control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences’ filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

Contacts

More News

View More
Biotech Breakouts: 3 Stocks With Massive Upside Potential
Via MarketBeat
Tickers IBRX MAZE VKTX
Powering Up: A Buy Rating Signals GE Vernova's AI Tailwinds
Via MarketBeat
Topics Artificial Intelligence Economy Energy
Tickers GEV
The Side of Rate Cuts Nobody Is Telling You About
Via MarketBeat
Topics Bonds Economy
Tickers CLSK IAU MP SPY TLT
Dave & Buster’s Stock: Is Now the Time to Make a PLAY?
Via MarketBeat
Tickers PLAY
Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing?
Via MarketBeat
Tickers LULU NKE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.